Search results

Page results

• Emily's Story (Acute Myeloid Leukaemia)

  My story started back in March 2012. As far as I could tell, it began as a cold in December 2011, accompanied by an inexplicable fatigue I could never quite shake off shortly after passing my…

• UCLH research study suggests ways to reduce COVID-19 infections in hospitals

  Researchers have highlighted the importance of routinely screening healthcare staff for SARS-CoV-2 after finding a high proportion of frontline staff had the virus at the peak of the pandemic.

• Researchers to see if sniffer dogs can detect COVID-19

  Could dogs offer quick and effective diagnosis of COVID-19?

• New national study on long-term health impacts of COVID-19 launched

  UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

• FAQ's

  About the Reproductive Medicine Unit

• Stem cell and bone marrow transplants (BMT) 

  The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.

• Blood transfusion

  A blood transfusion involves taking blood from a donor and giving it to someone else. UCLH is one of the largest and most complex blood establishments in the UK.

• Spread of COVID-19 mapped in hospitals to ‘break the chain’ of transmission

  UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.

• Single-dose radiotherapy as effective for treating breast cancer, long-term study finds

  A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.

• SUMMIT Study catches up with pre-pandemic follow up appointments

  As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.